Incidence and Clinical Features of Ganciclovir- Resistant Cytomegalovirus Disease in Heart Transplant Recipients
Open Access
- 15 August 2007
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 45 (4) , 439-447
- https://doi.org/10.1086/519941
Abstract
Background.The incidence and clinical and virologic aspects of ganciclovir-resistant cytomegalovirus (CMV) disease have not been well-characterized iKeywords
This publication has 23 references indexed in Scilit:
- Antiviral medications to prevent cytomegalovirus disease and early death in recipients of solid-organ transplants: a systematic review of randomised controlled trialsThe Lancet, 2005
- Efficacy and Safety of Valganciclovir vs. Oral Ganciclovir for Prevention of Cytomegalovirus Disease in Solid Organ Transplant RecipientsAmerican Journal of Transplantation, 2004
- Cytomegalovirus Disease in High-Risk Transplant Recipients Despite Ganciclovir or Valganciclovir ProphylaxisAmerican Journal of Transplantation, 2003
- Antiviral resistance in cytomegalovirus: An emerging problem in organ transplant recipientsSeminars in Respiratory Infections, 2002
- Ganciclovir‐Resistant Cytomegalovirus in Organ Transplant RecipientsClinical Infectious Diseases, 2002
- Prevention of primary cytomegalovirus disease in organ transplant recipients with oral ganciclovir or oral acyclovir prophylaxisTransplant Infectious Disease, 2000
- Prevention and treatment of cytomegalovirus disease in heart transplant patientsPublished by Elsevier ,2000
- Emergence of ganciclovir-resistant cytomegalovirus disease among recipients of solid-organ transplantsThe Lancet, 2000
- THE IMPACT OF GANCICLOVIR-RESISTANT CYTOMEGALOVIRUS INFECTION AFTER LUNG TRANSPLANTATIONTransplantation, 1999
- A Controlled Trial of Ganciclovir to Prevent Cytomegalovirus Disease after Heart TransplantationNew England Journal of Medicine, 1992